1. 292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients. (18th September 2019) Authors: Capilna, ME; Moldovan, B; Rad, C; Moldovan, AA; Cozlea, AL; Fandi, A; Gheorghe, M; Kiss, SL Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP811 A retrospective study regarding the role of cytoreductive surgery (CRS) and hypertermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer. (1st November 2019) Authors: Capilna, ME; Moldovan, B; Rad, C; Moldovan, AA; Cozlea, AL Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗